T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Zillow
Z
$7.48B
| $7.72M | ﹤0.01% |
87,585
+800
| +0.9% | +$80.9K |
|
1452
RB Global
RBA
$16B
| $7.65M | ﹤0.01% |
124,102
+11
| +0% | +$672 |
|
1453
Envista
NVST
$4.61B
| $7.6M | ﹤0.01% |
181,715
-7,258,165
| -98% | -$306M |
|
|
MASI
1454
DELISTED
Masimo
MASI
| $7.57M | ﹤0.01% |
27,953
+3,085
| +12% | +$836K |
|
1455
ZTO Express
ZTO
$17.6B
| $7.56M | ﹤0.01% |
246,537
-23,314
| -9% | -$669K |
|
1456
MoonLake Immunotherapeutics
MLTX
$1.47B
| $7.46M | ﹤0.01% |
756,303
| – | – |
|
1457
Arch Capital
ACGL
$33.2B
| $7.43M | ﹤0.01% |
194,629
-20,063
| -9% | -$795K |
|
|
BLSA
1458
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $7.37M | ﹤0.01% |
737,370
-675
| -0.1% | -$6.79K |
|
1459
Sixth Street Specialty
TSLX
$1.79B
| $7.33M | ﹤0.01% |
330,000
-225,000
| -41% | -$5.16M |
|
|
EUCRU
1460
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
| $7.28M | ﹤0.01% |
730,864
| – | – |
|
|
ONTF
1461
DELISTED
ON24
ONTF
| $7.26M | ﹤0.01% |
+364,277
| New | +$10.1M |
|
|
OLO
1462
DELISTED
Olo Inc
OLO
| $7.25M | ﹤0.01% |
+241,503
| New | +$8.62M |
|
1463
Canadian National Railway
CNI
$76.4B
| $7.07M | ﹤0.01% |
60,983
+37,275
| +157% | +$4.12M |
|
|
SBT
1464
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $6.91M | ﹤0.01% |
1,338,260
-1,395,040
| -51% | -$7M |
|
1465
VICI Properties
VICI
$29B
| $6.9M | ﹤0.01% |
242,836
-18,491
| -7% | -$564K |
|
|
GAP
1466
The Gap Inc
GAP
$7.29B
| $6.88M | ﹤0.01% |
303,260
-7,823
| -3% | -$216K |
|
1467
Fidelity National Financial
FNF
$12.8B
| $6.87M | ﹤0.01% |
157,504
-67,577
| -30% | -$3M |
|
|
VMW
1468
DELISTED
VMware, Inc
VMW
| $6.8M | ﹤0.01% |
45,716
+964
| +2% | +$146K |
|
1469
Sensata Technologies
ST
$6.72B
| $6.7M | ﹤0.01% |
122,477
-3,871
| -3% | -$223K |
|
1470
Aramark
ARMK
$16.1B
| $6.47M | ﹤0.01% |
272,625
-18,568
| -6% | -$460K |
|
1471
Crown Holdings
CCK
$13.1B
| $6.44M | ﹤0.01% |
63,946
-426
| -0.7% | -$44.7K |
|
|
CCXI
1472
DELISTED
ChemoCentryx, Inc.
CCXI
| $6.44M | ﹤0.01% |
376,622
-68,276
| -15% | -$1.06M |
|
1473
Grand Canyon Education
LOPE
$3.7B
| $6.43M | ﹤0.01% |
73,121
-1,193
| -2% | -$106K |
|
|
ELAT
1474
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
| $6.37M | ﹤0.01% |
128,052
-123
| -0.1% | -$6.41K |
|
1475
WillScot Mobile Mini Holdings
WSC
$4.17B
| $6.36M | ﹤0.01% |
200,500
-2,484
| -1% | -$71.8K |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.